Mental Health and Cognition in HIV Infection in Rakai Uganda

乌干达拉凯艾滋病毒感染者的心理健康和认知

• 批准号: 10252860
• 负责人: Robert H Paul
• 金额: $ 58.36万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-08-22 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10252860
• 关键词: Acute; Address; Adherence; Affect; Affective; Africa; Africa South of the Sahara; Anti-Anxiety Agents; Antidepressive Agents; Basic Science; Behavioral; Biological; Biological Markers; Biology; Brain; Categories; Cerebrovascular Disorders; Clinical Trials; Cocaine; Cognition; Cognitive; Cognitive Therapy; Cohort Studies; Complex; Data; Diabetes Mellitus; Dimensions; Disease; Emotions; Enrollment; Exposure to; Fright; Functional disorder; Funding; HIV; HIV Infections; HIV Seronegativity; HIV-associated neurocognitive disorder; Hepatitis C co-infection; Heterogeneity; Hypertension; Impairment; Individual; Inflammation; Infrastructure; Insulin; Intervention; Investigation; Knowledge; Lead; Learning; Literature; Longitudinal cohort; Major Depressive Disorder; Measures; Memory; Mental Depression; Mental Health; Mental disorders; Methodology; Motor; NIH Office of AIDS Research; Narcotics; National Institute of Mental Health; Negative Valence; Nervous System Physiology; Neuraxis; Neurocognitive Deficit; Neurology; Neurons; Neuropsychological Tests; Obesity; Outcome; Participant; Pathogenesis; Pattern; Pharmaceutical Preparations; Phenotype; Population; Prognosis; Research; Research Domain Criteria; Research Personnel; Research Priority; Risk Factors; Rural; Symptoms; System; Therapeutic Intervention; Thinking; Trauma; Treatment/Psychosocial Effects; Uganda; United States; United States National Institutes of Health; Violence; Viral reservoir; Visit; Women' s Interagency HIV Study; accurate diagnosis; antiretroviral therapy; axon injury; base; behavioral phenotyping; biomarker panel; clinically significant; cognitive control; cohort; comorbidity; cost; depressive symptoms; exosome; hypercholesterolemia; illicit drug use; improved; inflammatory marker; low income country; motor disorder; neurofilament protein L; novel; preservation; psychosocial; substance use; targeted treatment; therapy adherence

Mental health disorders including depression and neurocognitive impairment (NCI) are the most common central nervous system (CNS) complications of HIV infection despite effective antiretroviral therapy (ART). It is estimated that 40-50% of HIV+ individuals have at least one mental health disorder. Uganda, a low-income country in Sub- Saharan Africa (SSA) has ~1.5 million people living with HIV (PLWH) many of whom are on ART. Despite ART use, CNS complications, which are notably heterogeneous, persist among PLWH. Uganda provides a unique setting for advancing our understanding of major depressive disorder [MDD] and NCI, because common confounding conditions in the United States such as cerebrovascular disease risk factors and illicit drug use (e.g., narcotics, cocaine) are rare in Uganda. We propose to address the overarching hypothesis that there is substantial heterogeneity in MDD and NCI in PLWH and that psychosocial determinants (e.g., sexual and physical trauma, violence) are likely contributors to this heterogeneity. Addressing the heterogeneity in MDD and NCI is critical to advancing our understanding of cognitive phenotypes. To accomplish our aims, we will use a novel methodology for mental health in HIV research, the NIMH Research Domain Criteria (RDoC) framework, which recognizes heterogeneity, to first examine behavioral phenotypes among PLWH followed by studies to understand the functional consequences of these phenotypes and the underlying pathophysiology in these phenotypes. Our study results should lead to more accurate diagnosis, prognosis, and targeted interventions for MDD and NCI in HIV infection globally. We plan to cost-effectively leverage the established infrastructure and data from our previous Rakai Neurology Cohort Study to examine the following aims: Aim 1: Examine separate and interactive effects of HIV and psychosocial determinants on CNS dysfunction in PLWH. Hyp 1. Exposure to sexual/physical trauma or violence will interact with HIV in this population and will be associated with greater impairments/decline in declarative memory, cognitive control, and NVS. Aim 2: Examine effects of psychosocial determinants and CNS dysfunction on ART adherence in PLWH. Hyp 2. Exposure to sexual/physical trauma or violence and/or impairments/decline in declarative memory, cognitive control, and NVS will adversely affect ART adherence. Exploratory Aim 3: Determine biomarkers that relate most strongly and reliably to CNS dysfunction in the context of HIV and/or psychosocial determinants. Hyp 3: Different biomarkers of neuronal damage and CNS inflammation will relate to patterns of impairment/decline in declarative memory, cognitive control, motor, and NVS in the context of HIV and/or exposure to sexual/physical trauma or violence. We will also build capacity to evaluate and conduct research in mental health disorders and introduce new measures of adherence to our cohort. Our proposal addresses several high priority research topics for the NIH Office of AIDS Research including HIV-associated comorbidities, basic research to understand the pathogenesis of mental health disorders in HIV infection, and research to identify viral reservoirs that could lead to a cure for HIV infection.

包括抑郁症和神经认知障碍（NCI）在内的精神健康障碍是最常见的中枢疾病